Welcome
Support Centre
12 March 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Evaluation of mepivacaine ED95 for peripheral nerve blocks using ultrasound guidance
ISRCTN ISRCTN15749962
ClinicalTrials.gov identifier
Public title Evaluation of mepivacaine ED95 for peripheral nerve blocks using ultrasound guidance
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis To determine the 50% Effective Dose (ED50) and 95% Effective Dose (ED95) volume of 1% mepivacaine relative to the cross-sectional area of the ulnar nerve using ultrasound guidance for performance of an adequate sensory nerve block.
Ethics approval Ethics approval received from the local ethics committee (Kantonale Ethikkommission Bern [KEK]) on the 6th June 2006 (ref: 76/06).
Study design Up-and-down method study, patient is their own control. Volunteers and physician performing the block are blinded to the volume injected.
Countries of recruitment Switzerland
Disease/condition/study domain Peripheral regional anaesthesia
Participants - inclusion criteria 1. Healthy volunteers
2. Aged more than 18 and less than 70 years
Participants - exclusion criteria 1. Pregnancy
2. Sensory or motor abnormalities of the arm
3. Alcohol abuse
4. Intake of psychotropic drugs
5. Allergies to local anaesthetics
6. Intake of non-steroidal anti-inflammatory drugs the week preceding the study
7. Coagulation abnormalities
8. Coronary artery disease
9. Bacterical infection, systemic or local
10. Fever
Anticipated start date 01/08/2006
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material
Target number of participants 20
Interventions The ulnar nerve of the non-dominant forearm of the volunteer is scanned and its outer limit is tracked to calculate the cross-sectional area of the nerve. A short bevel facet tip ultrasound needle is advanced under direct ultrasonographic visualisation next to the nerve and the local anaesthetic is applied around the nerve.

The volume of local anaesthetic solution is calculated dependent on the measured cross-sectional area of the nerve, starting with 0.4 ml/mm^2 in the first volunteer. Each volunteer’s response determines the volume of local anaesthetic for the next volunteer. When sensory block is present within 20 minutes after injection, the volume for the next volunteer is decreased by 0.04 ml/mm^2. Conversely, when sensory block is insufficient, the volume for the next volunteer is increased by th same amount. After three cycles of dose reduction - dose augmentation the ED50 and ED 95 values will be calculated.

After the intervention, volunteers were controlled until total reversal of the block - that means 3 - 6 hours.
Primary outcome measure(s) Block success: complete sensory block within 20 minutes in the skin area of the blocked ulnar nerve tested by pinprick.
Secondary outcome measure(s) Duration of block.
Sources of funding 1. University of Bern (Switzerland) - Scientific fund of the Department of Anaesthesiology
2. Swiss Society of Anaesthesiology and Reanimation (SGAR) (Switzerland) - scientific fund
Trial website
Publications
Contact name Dr  Urs  Eichenberger
  Address Department of Anaesthesiology
University of Bern
Inselspital
  City/town Bern
  Zip/Postcode 3010
  Country Switzerland
  Email urs.eichenberger@insel.ch
Sponsor University of Bern (Switzerland) - Scientific fund of the Department of Anaesthesiology
  Address Department of Anaesthesiology
Inselspital
  City/town Bern
  Zip/Postcode 3010
  Country Switzerland
  Sponsor website: http://www.unibe.ch/eng/
Date applied 19/09/2007
Last edited 27/09/2007
Date ISRCTN assigned 27/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© ISRCTN


BioMed Central